2024 Q2 Form 10-Q Financial Statement

#000090725424000042 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $66.94M $66.69M
YoY Change 5.08% 5.78%
Cost Of Revenue $17.26M $18.17M
YoY Change 4.95% 11.6%
Gross Profit $49.68M $48.52M
YoY Change 5.12% 3.75%
Gross Profit Margin 74.21% 72.76%
Selling, General & Admin $6.102M $5.784M
YoY Change 7.47% 9.79%
% of Gross Profit 12.28% 11.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.00M $12.03M
YoY Change -0.93% 0.1%
% of Gross Profit 24.16% 24.79%
Operating Expenses $18.28M $18.16M
YoY Change 2.32% 5.62%
Operating Profit $31.40M $30.37M
YoY Change 6.82% 2.67%
Interest Expense $12.31M $12.48M
YoY Change -0.44% 4.61%
% of Operating Profit 39.18% 41.09%
Other Income/Expense, Net
YoY Change
Pretax Income $19.49M $18.26M
YoY Change 13.39% 3.4%
Income Tax
% Of Pretax Income
Net Earnings $14.45M $13.63M
YoY Change 9.77% 0.95%
Net Earnings / Revenue 21.58% 20.44%
Basic Earnings Per Share $0.48 $0.45
Diluted Earnings Per Share $0.48 $0.45
COMMON SHARES
Basic Shares Outstanding 23.98M shares 23.98M shares
Diluted Shares Outstanding 24.12M shares 24.10M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.863M $7.079M
YoY Change -40.18% -40.07%
Cash & Equivalents $6.863M $7.079M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $53.33M $53.81M
Other Receivables $0.00 $0.00
Total Short-Term Assets $60.19M $60.89M
YoY Change -5.09% -5.48%
LONG-TERM ASSETS
Property, Plant & Equipment $1.975B $1.932B
YoY Change 9.26% 9.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.83M $23.93M
YoY Change 13.31% 4.71%
Total Long-Term Assets $2.011B $1.969B
YoY Change 9.12% 9.19%
TOTAL ASSETS
Total Short-Term Assets $60.19M $60.89M
Total Long-Term Assets $2.011B $1.969B
Total Assets $2.072B $2.030B
YoY Change 8.65% 8.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.12M $60.59M
YoY Change 36.65% 14.99%
Accrued Expenses $2.200M $2.400M
YoY Change -24.14% -22.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $95.56M $86.12M
YoY Change 24.61% 10.05%
LONG-TERM LIABILITIES
Long-Term Debt $1.443B $1.409B
YoY Change 11.47% 12.61%
Other Long-Term Liabilities $20.42M $21.61M
YoY Change -6.5% -5.92%
Total Long-Term Liabilities $1.463B $1.430B
YoY Change 11.17% 12.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $95.56M $86.12M
Total Long-Term Liabilities $1.463B $1.430B
Total Liabilities $1.559B $1.516B
YoY Change 11.91% 12.14%
SHAREHOLDERS EQUITY
Retained Earnings -$294.9M -$292.2M
YoY Change 4.99% 5.48%
Common Stock $241.0K $241.0K
YoY Change 0.42% 0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $345.7M $347.1M
YoY Change
Total Liabilities & Shareholders Equity $2.072B $2.030B
YoY Change 8.65% 8.69%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $14.45M $13.63M
YoY Change 9.77% 0.95%
Depreciation, Depletion And Amortization $12.00M $12.03M
YoY Change -0.93% 0.1%
Cash From Operating Activities $32.13M $33.83M
YoY Change -1.42% -6.29%
INVESTING ACTIVITIES
Capital Expenditures $44.81M $45.57M
YoY Change -20.29% 5.59%
Acquisitions
YoY Change
Other Investing Activities $181.0K
YoY Change
Cash From Investing Activities -$44.63M -$45.57M
YoY Change -20.61% 5.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.28M $10.41M
YoY Change -47.25% 86.25%
NET CHANGE
Cash From Operating Activities 32.13M $33.83M
Cash From Investing Activities -44.63M -$45.57M
Cash From Financing Activities 12.28M $10.41M
Net Change In Cash -216.0K -$1.328M
YoY Change -36.28% -9.48%
FREE CASH FLOW
Cash From Operating Activities $32.13M $33.83M
Capital Expenditures $44.81M $45.57M
Free Cash Flow -$12.68M -$11.74M
YoY Change -46.33% 66.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24099077 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24099077 shares
CY2024Q1 us-gaap Other Operating Income
OtherOperatingIncome
1393000 usd
CY2023Q1 us-gaap Other Operating Income
OtherOperatingIncome
1220000 usd
CY2024Q1 us-gaap Revenues
Revenues
66692000 usd
CY2023Q1 us-gaap Revenues
Revenues
63049000 usd
CY2024Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
10545000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
8785000 usd
CY2024Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
7623000 usd
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
7495000 usd
CY2024Q1 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12448000 usd
CY2023Q1 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
11821000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12029000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12017000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5784000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5268000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
48429000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
45386000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
18263000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17663000 usd
CY2024Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
4633000 usd
CY2023Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
4161000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
13630000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13502000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2798000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2798000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10832000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10704000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2024Q1 us-gaap Profit Loss
ProfitLoss
18263000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17663000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1804000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2014000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
20067000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
15649000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5173000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3597000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14894000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12052000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2798000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2798000 usd
CY2024Q1 bfs Total Comprehensive Income Loss Available To Common Stockholders
TotalComprehensiveIncomeLossAvailableToCommonStockholders
12096000 usd
CY2023Q1 bfs Total Comprehensive Income Loss Available To Common Stockholders
TotalComprehensiveIncomeLossAvailableToCommonStockholders
9254000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
504429000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
16007 shares
CY2024Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
603000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
183 shares
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
219000 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
20330000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
0 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14208000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14171000 usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5930000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5486000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10413000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
513931000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
521802000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
13227 shares
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
543000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
699 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
290000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17663000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2014000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
19651000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
515835000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
18263000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17663000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12029000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12017000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
564000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
559000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
219000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
290000 usd
CY2024Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
342000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-96000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-1876000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-3805000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
1262000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
1519000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-377000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1083000 usd
CY2024Q1 bfs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
2558000 usd
CY2023Q1 bfs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
2495000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1138000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
199000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33828000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36098000 usd
CY2024Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
5832000 usd
CY2023Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
5019000 usd
CY2024Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
39737000 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
38137000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45569000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43156000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
15300000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8527000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
17419000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
27000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
41000000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
29000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
11000000 usd
CY2024Q1 us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
31533000 usd
CY2023Q1 us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
0 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
378000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
603000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
543000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
11741000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5591000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1328000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1467000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8407000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13279000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7079000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11812000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
11960000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11002000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
34573000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
29323000 usd
CY2024Q1 bfs Minimum Percentage Of Taxable Income Distribution To Shareholders
MinimumPercentageOfTaxableIncomeDistributionToShareholders
0.90
CY2024Q1 bfs Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
CY2024Q1 us-gaap Number Of Stores
NumberOfStores
34 store
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates and assumptions relate to collectability of operating lease receivables and impairment of real estate properties. Actual results could differ from those estimates.</span></div>
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year financial statements to conform to the presentation used as of and for the three months ended March 31, 2024.</span></div>
CY2024Q1 us-gaap Development In Process
DevelopmentInProcess
557711000 usd
CY2023Q4 us-gaap Development In Process
DevelopmentInProcess
514553000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2300000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2400000 usd
CY2024Q1 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
23900000 usd
CY2023Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
23700000 usd
CY2024Q1 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
54200000 usd
CY2023Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
53700000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11000000 usd
CY2024Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
5000000 usd
CY2023Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
3300000 usd
CY2024Q1 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
9900000 shares
CY2022Q3 bfs Number Of Interest Rate Swaps
NumberOfInterestRateSwaps
2 swap
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1430000000 usd
CY2024Q1 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1150000000 usd
CY2024Q1 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
274000000 usd
CY2024Q1 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1560000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1410000000 usd
CY2023Q4 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1130000000 usd
CY2023Q4 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
276000000 usd
CY2023Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1520000000 usd
CY2024Q1 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsRemainderOfFiscalYear
75457000 usd
CY2024Q1 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year One
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearOne
326086000 usd
CY2024Q1 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearTwo
163051000 usd
CY2024Q1 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearThree
126589000 usd
CY2024Q1 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFour
44770000 usd
CY2024Q1 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFive
52627000 usd
CY2024Q1 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsAfterYearFive
638711000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1427291000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
18641000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1408650000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
18600000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19300000 usd
CY2024Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
11300000 usd
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
10600000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
18084000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
15513000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
564000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
559000 usd
CY2024Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
6168000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
4142000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
12480000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
11930000 usd
CY2024Q1 us-gaap Interest Income Operating
InterestIncomeOperating
32000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
109000 usd
CY2024Q1 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12448000 usd
CY2023Q1 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
11821000 usd
CY2024Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
4600000 usd
CY2023Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
4200000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24094000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24026000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24097000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24026000 shares
CY2024Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2024Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
118000 usd
CY2023Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
111800 usd
CY2024Q1 bfs Deferred Compensation Arrangement With Individual Contributions By Plan Participants Percentage Of Salary Maximum
DeferredCompensationArrangementWithIndividualContributionsByPlanParticipantsPercentageOfSalaryMaximum
0.02
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
49300 usd
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
63000 usd
CY2024Q1 bfs Deferred Compensation Arrangement With Individual Employer Contribution Percentage Deferred Compensation
DeferredCompensationArrangementWithIndividualEmployerContributionPercentageDeferredCompensation
3
CY2023Q1 bfs Deferred Compensation Arrangement With Individual Employer Contribution Percentage Deferred Compensation
DeferredCompensationArrangementWithIndividualEmployerContributionPercentageDeferredCompensation
3
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3200000 usd
CY2023Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3300000 usd
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
1991 shares
CY2023Q2 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
117382 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1700000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1820000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.41
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1197380 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 bfs Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
0 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
240625 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
52.41
CY2024Q1 bfs Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1579375 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.95
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1008150 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
997375 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
52.15
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
141000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q3 us-gaap Share Price
SharePrice
38.49
CY2023Q3 bfs Share Based Compensation Arrangement By Share Based Payment Award Options Grants Since Inception
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsSinceInception
1400000 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2024Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
947800000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
957900000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
1150000000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1130000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
2411000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-1618000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-608000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-396000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Revenues
Revenues
66692000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18168000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
48524000 usd
CY2024Q1 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12448000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12029000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5784000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
18263000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
45569000 usd
CY2024Q1 us-gaap Assets
Assets
2030306000 usd
CY2023Q1 us-gaap Revenues
Revenues
63049000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16280000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
46769000 usd
CY2023Q1 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
11821000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12017000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5268000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17663000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
43156000 usd
CY2023Q1 us-gaap Assets
Assets
1868005000 usd

Files In Submission

Name View Source Status
0000907254-24-000042-index-headers.html Edgar Link pending
0000907254-24-000042-index.html Edgar Link pending
0000907254-24-000042.txt Edgar Link pending
0000907254-24-000042-xbrl.zip Edgar Link pending
bfs-03312024xex31.htm Edgar Link pending
bfs-03312024xex32.htm Edgar Link pending
bfs-03312024xex99a.htm Edgar Link pending
bfs-20240331.htm Edgar Link pending
bfs-20240331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
bfs-20240331_cal.xml Edgar Link unprocessable
bfs-20240331_def.xml Edgar Link unprocessable
bfs-20240331_lab.xml Edgar Link unprocessable
bfs-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bfs-20240331_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending